News
August 01, 2023 | Amygdala Press Release Amygdala Neurosciences (a private company) has been awarded a $2.0 million NIH grant to support the project titled "Investigational New Drug (IND)-enabling and Early-Stage Development of Selective, Reversible, Orally Bioavailable ALDH2 inhibitor ANS-00858 to Treat Alcohol Use Disorder." This award is made from the National Institute on Alcohol Abuse and Alcoholism (NIAAA, an Institute of the National Institutes of Health (NIH)). July 28, 2023 | Wall Street Journal Scientists are finding ways to help people sober up faster and feel fewer bad efects November 18, 2019 | NBC News The National Institutes of Health in Bethesda, Maryland, is testing an experimental drug that could save lives in the fight against the opioid epidemic. October 17, 2019 | Amygdala Press Release ANS-6637 is a new chemical entity selective ALDH2 Inhibitor with a mechanism of action expected to prevent craving and relapse for patients being treated for substance use disorders including… March 28, 2019 | Amygdala Press Release March 21, 2019 | NIH Press Release A clinical trial of an experimental drug designed to treat cravings associated with opioid use disorder (OUD) has begun in the National Institutes of Health Clinical Center. September 19, 2018 | NIH/IHV Press Release February 16, 2017 | Amygdala Press Release
Amygdala Neurosciences Awarded $2.0 million NIH Grant to Conduct IND Enabling Studies
Enjoy Alcohol, Without the Hangover
NIH Experiments With Drug to Reduce Opioid Cravings
Amygdala Neurosciences Announces Dosing of the First Patient in the NIH Funded Phase 2 Proof-Of-Concept study of ANS-6637 for the Treatment of Alcohol Use Disorder
Amygdala Neurosciences Announces Dosing the First Patients in the $12.4 Million NIH HEAL Initiative Funded SEARCH Program of Clinical Studies with ANS-6637
NIH to Test Experimental Drug to Curb Opioid Cravings
Institute of Human Virology (IHV) Awarded $12M to Combat Opioid Epidemic Through Clinical Research Trials
Amygdala Neurosciences Acquires GS-6637 from Gilead